Soluble adhesion molecules in rheumatoid arthritis. 2000

E L Nassonov, and M Y Samsonov, and N V Chichasova, and E L Nikiphorova, and G P Tilz, and U Demel, and B Widner, and D Fuchs

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000943 Antigens, Differentiation Antigens expressed primarily on the membranes of living cells during sequential stages of maturation and differentiation. As immunologic markers they have high organ and tissue specificity and are useful as probes in studies of normal cell development as well as neoplastic transformation. Differentiation Antigen,Differentiation Antigens,Differentiation Antigens, Hairy Cell Leukemia,Differentiation Marker,Differentiation Markers,Leu Antigen,Leu Antigens,Marker Antigen,Marker Antigens,Markers, Differentiation,Antigen, Differentiation,Antigen, Leu,Antigen, Marker,Antigens, Leu,Antigens, Marker,Marker, Differentiation
D001172 Arthritis, Rheumatoid A chronic systemic disease, primarily of the joints, marked by inflammatory changes in the synovial membranes and articular structures, widespread fibrinoid degeneration of the collagen fibers in mesenchymal tissues, and by atrophy and rarefaction of bony structures. Etiology is unknown, but autoimmune mechanisms have been implicated. Rheumatoid Arthritis
D015703 Antigens, CD Differentiation antigens residing on mammalian leukocytes. CD stands for cluster of differentiation, which refers to groups of monoclonal antibodies that show similar reactivity with certain subpopulations of antigens of a particular lineage or differentiation stage. The subpopulations of antigens are also known by the same CD designation. CD Antigen,Cluster of Differentiation Antigen,Cluster of Differentiation Marker,Differentiation Antigens, Leukocyte, Human,Leukocyte Differentiation Antigens, Human,Cluster of Differentiation Antigens,Cluster of Differentiation Markers,Antigen Cluster, Differentiation,Antigen, CD,CD Antigens,Differentiation Antigen Cluster,Differentiation Marker Cluster,Marker Cluster, Differentiation
D015815 Cell Adhesion Molecules Surface ligands, usually glycoproteins, that mediate cell-to-cell adhesion. Their functions include the assembly and interconnection of various vertebrate systems, as well as maintenance of tissue integration, wound healing, morphogenic movements, cellular migrations, and metastasis. Cell Adhesion Molecule,Intercellular Adhesion Molecule,Intercellular Adhesion Molecules,Leukocyte Adhesion Molecule,Leukocyte Adhesion Molecules,Saccharide-Mediated Cell Adhesion Molecules,Saccharide Mediated Cell Adhesion Molecules,Adhesion Molecule, Cell,Adhesion Molecule, Intercellular,Adhesion Molecule, Leukocyte,Adhesion Molecules, Cell,Adhesion Molecules, Intercellular,Adhesion Molecules, Leukocyte,Molecule, Cell Adhesion,Molecule, Intercellular Adhesion,Molecule, Leukocyte Adhesion,Molecules, Cell Adhesion,Molecules, Intercellular Adhesion,Molecules, Leukocyte Adhesion
D016207 Cytokines Non-antibody proteins secreted by inflammatory leukocytes and some non-leukocytic cells, that act as intercellular mediators. They differ from classical hormones in that they are produced by a number of tissue or cell types rather than by specialized glands. They generally act locally in a paracrine or autocrine rather than endocrine manner. Cytokine
D018799 Intercellular Adhesion Molecule-1 A cell-surface ligand involved in leukocyte adhesion and inflammation. Its production is induced by gamma-interferon and it is required for neutrophil migration into inflamed tissue. Antigens, CD54,CD54 Antigens,ICAM-1,CD54 Antigen,Antigen, CD54,Intercellular Adhesion Molecule 1

Related Publications

E L Nassonov, and M Y Samsonov, and N V Chichasova, and E L Nikiphorova, and G P Tilz, and U Demel, and B Widner, and D Fuchs
September 1999, The Journal of rheumatology,
E L Nassonov, and M Y Samsonov, and N V Chichasova, and E L Nikiphorova, and G P Tilz, and U Demel, and B Widner, and D Fuchs
January 2005, Current pharmaceutical design,
E L Nassonov, and M Y Samsonov, and N V Chichasova, and E L Nikiphorova, and G P Tilz, and U Demel, and B Widner, and D Fuchs
January 1998, Springer seminars in immunopathology,
E L Nassonov, and M Y Samsonov, and N V Chichasova, and E L Nikiphorova, and G P Tilz, and U Demel, and B Widner, and D Fuchs
May 1995, Current opinion in rheumatology,
E L Nassonov, and M Y Samsonov, and N V Chichasova, and E L Nikiphorova, and G P Tilz, and U Demel, and B Widner, and D Fuchs
August 1996, Drugs & aging,
E L Nassonov, and M Y Samsonov, and N V Chichasova, and E L Nikiphorova, and G P Tilz, and U Demel, and B Widner, and D Fuchs
September 1995, British journal of rheumatology,
E L Nassonov, and M Y Samsonov, and N V Chichasova, and E L Nikiphorova, and G P Tilz, and U Demel, and B Widner, and D Fuchs
March 2023, Clinical rheumatology,
E L Nassonov, and M Y Samsonov, and N V Chichasova, and E L Nikiphorova, and G P Tilz, and U Demel, and B Widner, and D Fuchs
January 1999, Terapevticheskii arkhiv,
E L Nassonov, and M Y Samsonov, and N V Chichasova, and E L Nikiphorova, and G P Tilz, and U Demel, and B Widner, and D Fuchs
March 1992, Nihon rinsho. Japanese journal of clinical medicine,
E L Nassonov, and M Y Samsonov, and N V Chichasova, and E L Nikiphorova, and G P Tilz, and U Demel, and B Widner, and D Fuchs
May 1994, Current opinion in rheumatology,
Copied contents to your clipboard!